Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.75.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-829.135France
BA.2.75.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.75.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.66ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.66ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.66ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.66NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.3.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.3.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
BN.1.3.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BN.1.3.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-10155.5China
CH.1.1.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BM.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BM.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.19ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.19NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used